Impact Report 2020

This was a banner year filled with momentum, innovation, partnerships and incredible progress. Not only did we make exciting advances in research towards cures, but we also funded promising studies for new therapies that could prevent or delay the onset of type 1 diabetes (T1D), and reduce the risk of complications for the more than 300,000 Canadians burdened each day – and the millions more that live with T1D worldwide.

Read Now

Stay connected on the latest